Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund

Contributed by: Business Wire

Logo

Tags

Infectious Diseases

Biotechnology

Pharmaceutical

Health

GHIC

More Like This

Meiji Seika Pharma Opens New Office in Boston Area to Pursue Investment Opportunities in Innovative Drugs and Technologies

Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery

Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing

Meiji Seika Pharma Invests in MPM BioImpact’s New Technologies and Virology Strategy

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform

Nihon Medi-Physics headquarters and woman looking at molecular imaging images (Photo: Business Wire)

GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

Shiseido Announces Launch of Venture Fund

PR Newswire associated0

Japan International Cooperation Agency (JICA) commits $20 million to Horizon Capital Growth Fund IV (HCGF IV), marking firm's first Japanese backer